tiprankstipranks
Biosyent Inc (TSE:RX)
TSXV:RX
Canadian Market
Holding TSE:RX?
Track your performance easily

Biosyent (RX) Financial Statements

44 Followers

Biosyent Financial Overview

Biosyent's market cap is currently ―. The company's EPS TTM is C$0.61; its P/E ratio is 18.44; and it has a dividend yield of 1.55%. Biosyent is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is C$0.15. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total RevenueC$ 9.56MC$ 8.94MC$ 7.73MC$ 8.27MC$ 8.87M
Gross ProfitC$ 7.49MC$ 7.07MC$ 6.14MC$ 6.70MC$ 7.06M
EBITC$ 2.99MC$ 2.17MC$ 2.42MC$ 1.87MC$ 3.08M
EBITDAC$ 3.11MC$ 2.29MC$ 2.54MC$ 1.99MC$ 3.19M
Net Income Common StockholdersC$ 2.31MC$ 1.58MC$ 1.77MC$ 1.45MC$ 2.35M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 17.06MC$ 17.41MC$ 23.69MC$ 26.19MC$ 29.29M
Total AssetsC$ 45.47MC$ 41.48MC$ 40.00MC$ 41.53MC$ 41.40M
Total DebtC$ 1.08MC$ 1.13MC$ 1.18MC$ 1.22MC$ 1.27M
Net DebtC$ -15.98MC$ -16.28MC$ -22.51MC$ -24.97MC$ -28.02M
Total LiabilitiesC$ 8.12MC$ 6.06MC$ 5.44MC$ 6.77MC$ 6.85M
Stockholders EquityC$ 37.35MC$ 35.42MC$ 34.55MC$ 34.76MC$ 34.55M
Cash Flow-
Free Cash FlowC$ 2.00MC$ -1.63MC$ 944.94KC$ 622.65KC$ 2.39M
Operating Cash FlowC$ 6.60MC$ -1.51MC$ 955.60KC$ 674.99KC$ 2.41M
Investing Cash FlowC$ -5.04MC$ 7.16MC$ 283.88KC$ -916.50KC$ -976.08K
Financing Cash FlowC$ -554.72KC$ -913.23KC$ -2.16MC$ -1.29MC$ -1.14M
Currency in CAD

Biosyent Earnings and Revenue History

Biosyent Debt to Assets

Biosyent Cash Flow

Biosyent Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis